Literature DB >> 19798466

Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test.

Danila Di Giuseppe1, Monica Ulivelli, Sabina Bartalini, Stefania Battistini, Alfonso Cerase, Stefano Passero, Domenico Summa, Simona Frosali, Raffaella Priora, Antonios Margaritis, Paolo Di Simplicio.   

Abstract

Increases in plasma concentrations of total homocysteine (tHcy) have recently been reported in multiple sclerosis (MS) as the alteration of the methionine cycle for the onset of autoimmune diseases. Homocysteine (Hcy) and cysteine (Cys) are generated by the methionine cycle and transsulfuration reactions. Their plasma levels are subjected to complex redox changes by oxidation and thiol/disulfide (SH/SS) exchange reactions regulated by albumin. The methionine loading test (MLT) is a useful in vivo test to assay the functionality of the methionine cycle and transsulfuration reactions. Time courses of redox species of Cys, cysteinylglycine (CGly), Hcy, and glutathione have been investigated in plasma of MS patients versus healthy subjects after an overnight fasting, and 2, 4, and 6 h after an oral MLT (100 mg/kg body weight), to detect possible dysfunctions of the methionine cycle, transsulfuration reactions and alterations in plasma distribution of redox species. After fasting, the MS group showed a significant increase in cysteine-protein mixed disulfides (bCys) and total Cys (tCys). While plasma bCys and tCys in MS group remained elevated after methionine administration when compared to control, cystine (oxCys) increased significantly with respect to control. Although increased plasma concentrations of bCys and tCys at fasting might reflect an enhance of transsulfuration reactions in MS patients, this was not confirmed by the analysis of redox changes of thiols and total thiols after MLT. This study has also demonstrated that albumin-dependent SH/SS exchange reactions are a potent regulation system of thiol redox species in plasma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19798466     DOI: 10.1007/s00726-009-0350-8

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  8 in total

1.  Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender.

Authors:  Stefano Zoccolella; Carla Tortorella; Pietro Iaffaldano; Vita Direnzo; Mariangela D'Onghia; Damiano Paolicelli; Paolo Livrea; Maria Trojano
Journal:  J Neurol       Date:  2012-03-16       Impact factor: 4.849

2.  Redox-active magnetic resonance imaging contrast agents: studies with thiol-bearing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid derivatives.

Authors:  Bhumasamudram Jagadish; Gerald P Guntle; Dezheng Zhao; Vijay Gokhale; Tarik J Ozumerzifon; Ali M Ahad; Eugene A Mash; Natarajan Raghunand
Journal:  J Med Chem       Date:  2012-11-28       Impact factor: 7.446

3.  Comparative effects of acute-methionine loading on the plasma sulfur-amino acids in NAC-supplemented HIV+ patients and healthy controls.

Authors:  Roberto Carlos Burini; Maria Doroteia Borges-Santos; Fernando Moreto; Yong- Ming Yu
Journal:  Amino Acids       Date:  2018-02-01       Impact factor: 3.520

4.  Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.

Authors:  Maira Gironi; Bruno Borgiani; Enrica Mariani; Cristina Cursano; Laura Mendozzi; Rossella Cavarretta; Marina Saresella; Mario Clerici; Giancarlo Comi; Marco Rovaris; Roberto Furlan
Journal:  J Immunol Res       Date:  2014-03-26       Impact factor: 4.818

5.  Low serum levels of uric acid and albumin in patients with Guillain-Barre syndrome.

Authors:  Zhongqian Su; Zhibo Chen; Yian Xiang; Bingjie Wang; Yuanyuan Huang; Dehao Yang; Xiang Li; Yiyun Weng; XianFeng Lin; Guoqian Chen; Wenyue Liu; Chenchen Zhao; Qingqing Wang; Shanshan Li; Ying Chen; Ying Chen; Weiwei Quan; Qiuling Tong; Shengjie Wu; Shihao Huang; Peina Mei; Zhengzheng Li; Jia Li; Shengtao Hou; Xu Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  Low serum bilirubin, albumin, and uric acid levels in patients with Crohn's disease.

Authors:  Qisheng Su; Xiaohong Li; Wuning Mo; Zheng Yang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Redox processes in neurodegenerative disease involving reactive oxygen species.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

Review 8.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.